AHIMA, CHIME partner to advance HIM, HIT

The American Health Information Management Association (AHIMA) and the College of Healthcare Information Management Executives (CHIME) will work together on two timely and critically important issues--information governance and standards--to advance health information management (HIM) and health IT.

Aspects of the partnership include:

  • Research on HIM and HIT topics
  • Jointly sponsored webinars led by AHIMA subject matter experts and CHIME CIO representatives. Planned topics for 2013 include information governance for healthcare, ICD-10 readiness and implementation and HIM and HIT priorities for rural and critical access hospitals.
  • Presentations together on patient identity management and information governance for healthcare at the CHIME13 Fall CIO Forum
  • Advocacy efforts on key HIM and HIT issues
  • Reciprocal invitations for annual conferences, forums and summits

“AHIMA and CHIME both believe that the effective use of health information leads to better healthcare and outcomes for patients,” said AHIMA CEO Lynne Thomas Gordon, MBA, RHIA, CAE. “By working as strategic partners on these types of issues, we can make more progress than we would individually.”

“CHIME is excited to work in partnership with AHIMA as we focus our combined expertise, resources, reach and influence to further our collective goals and support our members," said CHIME President and CEO Russel P. Branzell, CHCIO. "This partnership underscores our commitment to drive the effective use of health information technology for improved safety, quality and efficiency of care delivery and reflects our desire to collaborate with organizations that share a similar vision.”

 

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.